Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - dust allergens, quantity: 0.97 ml/ml (equivalent: dust allergens, qty 97 mg/ml); dust allergens, quantity: 0.01 ml/ml (equivalent: dust allergens, qty 1 mg/ml); feathers, quantity: 0.003 ml/ml (equivalent: feathers, qty 0.3 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.01 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - 0.01 ic/ml - active: allergen extracts 0.01 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Канада - Енглески - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Канада - Енглески - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Канада - Енглески - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Канада - Енглески - Health Canada

greer laboratories inc - standardized kentucky blue/june grass pollen; standardized orchard grass pollen; standardized redtop grass pollen; standardized timothy grass pollen - solution - 10000unit; 10000unit; 10000unit; 10000unit - standardized kentucky blue/june grass pollen 10000unit; standardized orchard grass pollen 10000unit; standardized redtop grass pollen 10000unit; standardized timothy grass pollen 10000unit - allergenic extracts

Канада - Енглески - Health Canada

greer laboratories inc - standardized kentucky blue/june grass pollen; standardized orchard grass pollen; standardized redtop grass pollen; standardized timothy grass pollen - solution - 100000unit; 100000unit; 100000unit; 100000unit - standardized kentucky blue/june grass pollen 100000unit; standardized orchard grass pollen 100000unit; standardized redtop grass pollen 100000unit; standardized timothy grass pollen 100000unit - allergenic extracts

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 1000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

alk-abello, inc. - acacia longifolia pollen (unii: 24so2j296o) (acacia longifolia pollen - unii:24so2j296o) - acacia longifolia pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

alk-abello, inc. - dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p) - dactylis glomerata pollen 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w